Publications

2022
Michael Blanding. 6/21/2022. “Bringing heart and humanity to hematology.” Harvard T.H. Chan School of Public Health. Read here
Ajay Major, Edward RS Cliff, Daniel Ermann, Urshila Durani, and David Russler-Germain. 6/16/2022. “Frontline polatuzumab vedotin for diffuse large B-cell lymphoma: A survey of clinician impressions.” eJHaem. Publisher's Version
Edward RS Cliff. 4/7/2022. “A Decision Shared is a Decision Halved.” JAMA Oncology. Read hereAbstract

 

Dealing with cancer, and making decisions about treatment, is hard enough in its own right, harshly compounded by the immense loneliness enforced by banning visitors from our wards. As we try to protect the most vulnerable in our community from the pandemic, I just hope that we are not losing sight of our humanity and compassion along the way.

Edward RS Cliff. 3/28/2022. “The rollercoaster of vaccine-induced immune thrombotic thrombocytopenia.” The Lancet Haematology. Read here
Edward Cliff, Isaac Chan, and Salmaan Keshavjee. 1/19/2022. “5 steps we must take to vaccinate the world's vulnerable and end the pandemic.” NPR. Read here
2021
Edward RS Cliff, Joe Sasadeusz, Kumar Visvanathan, and Andrew Grigg. 12/2/2021. “Very late-onset hepatitis B reactivation following chemoimmunotherapy.” Leukemia & Lymphoma. Read here
Edward RS Cliff and Jeff Szer. 11/18/2021. “We must grow the Australian Bone Marrow Donor Registry.” Internal Medicine Journal. Read here
Thomas E Lew, Victor S Lin, Edward RS Cliff, Piers Blombery, Ella R Thompson, Sasanka M Handunnetti, David A Westerman, Bryone J Kuss, Constantine S Tam, David CS Huang, John F Seymour, Andrew W Roberts, and Mary Ann Anderson. 10/20/2021. “Outcomes of patients with CLL sequentially resistant to both BCL2 and BTK inhibition.” Blood Advances, 5, 20, Pp. 4054–4058. Read here
Edward Cliff and Brian Fernandes. 9/8/2021. “Covid Zero Is No Longer Working for Australia.” The New York Times. Read here
Thomas E Lew*, Edward RS Cliff*, Michael Dickinson, Constantine S Tam, John F Seymour, Piers Blombery, Ashish Bajel, David Ritchie, and Amit Khot. 7/20/2021. “T-cell replete allogeneic stem cell transplant for mantle cell lymphoma achieves durable disease control, including against TP53-mutated disease.” Bone Marrow Transplantation. Read here
2018
Shivani Misra, Natascia Vedovato, Edward Cliff, Elisa De Franco, Andrew T Hattersley, Frances M Ashcroft, and Nick Oliver. 6/13/2018. “Permanent neonatal diabetes: combining sulfonylureas with insulin may be an effective treatment .” Diabetic Medicine. Read here
Edward Cliff. 5/28/2018. “Bringing public health into the digital age.” MJA Insight. Read here
2017
Brian Fernandes, Edward RS Cliff, and Amelia Chowdhury. 7/17/2017. “Achieving self-sufficiency: training Australia’s future medical workforce.” Australian Health Review. Read here
2016
Daniel D'Hotman and Edward Cliff. 10/16/2016. “We need a soft drink tax if we're going to beat the obesity epidemic.” The Sydney Morning Herald. Read here
Jessica M Dean, Edward RS Cliff, Karen Freilich, and Molly Gilfillan. 5/16/2016. “A campaign to improve the mental health of medical students.” The Medical Journal of Australia. Read here
Natascia Vedovato, Edward RS Cliff, Peter Proks, Varadarajan Poovazhagi, Sarah E Flanagan, Sian Ellard, Andrew T Hattersley, and Frances M Ashcroft. 4/27/2016. “Neonatal diabetes caused by a homozygous KCNJ11 mutation demonstrates that tiny changes in ATP sensitivity markedly affect diabetes risk.” Diabetologia, 59, Pp. 1430–1436. Read here